K170349 is an FDA 510(k) clearance for the RA-308 Excimer Laser System, Excimer Laser Catheter. Classified as Catheter For Crossing Total Occlusions (product code PDU), Class II - Special Controls.
Submitted by Ra Medical Systems,Inc (Carlsbad, US). The FDA issued a Cleared decision on May 24, 2017 after a review of 110 days - within the typical 510(k) review window.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
View all Ra Medical Systems,Inc devices
NCT02653456
Completed
Interventional
Industry-sponsored
Evaluating Plaque Photoablation Using an Excimer Laser in Patients With Lower Extremity Vascular Disease
A Prospective, Multi Center Pilot Study Evaluating Plaque Photoablation Using the RA-308 Excimer Laser in Subjects With Symptomatic Infrainguinal Lower Extremity Vascular Disease
| Condition studied |
Peripheral Arterial Disease |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Ehtisham Mahmud |
| Sponsor |
Ra Medical Systems
(industry)
|
Started 2016-04-07
→
Primary completion 2017-05-03
→
Completed 2017-07-14
Primary outcome
Crossing the Target Lesion
Secondary outcome
Number of Participants With no Device-related Major Adverse Events
View full study on ClinicalTrials.gov